Agilent Technologies (A) has drawn investor attention after recent share performance, with the stock showing negative returns over the past month and past 3 months while remaining positive over a 5 ...

Revenue: $1.8 billion, growing 4.4% on a core basis. Operating Margin: 24.6%, in line with expectations. EPS: $1.36, within expectations. Gross Margin: 53.7%, down 100 basis points year over year.

Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, where it is seeing growth opportunities, the type of research it is supporting and ...

The Genomics Core offers a wide range of DNA library preps from whole-genome PCR free to amplicon sequencing and CRISPR-Cas 9 validation. We also work with users to complete ChIP-seq and CUT&RUN ...

Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...

Valued at a market cap of $34.5 billion, Agilent Technologies, Inc. (A) is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets.

Agilent Technologies, a major player in life sciences and chemical analysis, faces cyclical and structural challenges but shows potential for growth in FY 2025. Despite a strong global presence and ...

Aug 21 (Reuters) - Agilent Technologies (A.N), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass ...